ES2162678T3 - NEW DIARILMETILIDENO FURANIC DERIVATIVES, THEIR PREPARATION PROCEDURES AND THEIR USES IN THERAPEUTICS. - Google Patents

NEW DIARILMETILIDENO FURANIC DERIVATIVES, THEIR PREPARATION PROCEDURES AND THEIR USES IN THERAPEUTICS.

Info

Publication number
ES2162678T3
ES2162678T3 ES97919476T ES97919476T ES2162678T3 ES 2162678 T3 ES2162678 T3 ES 2162678T3 ES 97919476 T ES97919476 T ES 97919476T ES 97919476 T ES97919476 T ES 97919476T ES 2162678 T3 ES2162678 T3 ES 2162678T3
Authority
ES
Spain
Prior art keywords
diarilmetilideno
therapeutics
new
preparation procedures
furanic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919476T
Other languages
Spanish (es)
Inventor
Eric Nicolai
Jean-Marie Teulon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNION PHARMA SCIENT APPL
UPSA SAS
Original Assignee
UNION PHARMA SCIENT APPL
UPSA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNION PHARMA SCIENT APPL, UPSA SAS filed Critical UNION PHARMA SCIENT APPL
Application granted granted Critical
Publication of ES2162678T3 publication Critical patent/ES2162678T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

LA PRESENTE INVENCION SE REFIERE A LOS DERIVADOS DIARILMETILIDENO FURANICOS DE FORMULA (I) Y SU UTILIZACION TERAPEUTICA PARTICULARMENTE COMO MEDICAMENTOS CON PROPIEDADES ANTIINFLAMATORIAS Y ANTALGICOS.THE PRESENT INVENTION REFERS TO FURANIC DIARILMETILIDEN DERIVATIVES OF FORMULA (I) AND ITS PARTICULAR THERAPEUTIC USE AS MEDICINES WITH ANTI-INFLAMMATORY AND ANTALGICAL PROPERTIES.

ES97919476T 1996-04-04 1997-04-03 NEW DIARILMETILIDENO FURANIC DERIVATIVES, THEIR PREPARATION PROCEDURES AND THEIR USES IN THERAPEUTICS. Expired - Lifetime ES2162678T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604236A FR2747123B1 (en) 1996-04-04 1996-04-04 NOVEL DIARYLMETHYLIDENE TETRAHYDROFURANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THERAPEUTIC USES
FR9607922A FR2747124B1 (en) 1996-04-04 1996-06-26 NOVEL FURANIC DIARYLMETHYLIDENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES

Publications (1)

Publication Number Publication Date
ES2162678T3 true ES2162678T3 (en) 2002-01-01

Family

ID=9490907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919476T Expired - Lifetime ES2162678T3 (en) 1996-04-04 1997-04-03 NEW DIARILMETILIDENO FURANIC DERIVATIVES, THEIR PREPARATION PROCEDURES AND THEIR USES IN THERAPEUTICS.

Country Status (28)

Country Link
EP (1) EP0891345B1 (en)
JP (1) JP2000508638A (en)
KR (1) KR20000005146A (en)
CN (1) CN1215396A (en)
AR (1) AR006539A1 (en)
AT (1) ATE204268T1 (en)
AU (1) AU717146B2 (en)
BG (1) BG62808B1 (en)
BR (1) BR9708510A (en)
CA (1) CA2248949A1 (en)
CZ (1) CZ318898A3 (en)
DE (1) DE69706157T2 (en)
DK (1) DK0891345T3 (en)
EE (1) EE03687B1 (en)
ES (1) ES2162678T3 (en)
FR (2) FR2747123B1 (en)
GE (1) GEP20032924B (en)
IL (1) IL126105A (en)
NO (1) NO984624L (en)
NZ (1) NZ331672A (en)
PL (1) PL329213A1 (en)
PT (1) PT891345E (en)
RU (1) RU2189979C2 (en)
SI (1) SI0891345T1 (en)
SK (1) SK283292B6 (en)
TW (1) TW353660B (en)
WO (1) WO1997037984A1 (en)
ZA (1) ZA972894B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180651B1 (en) * 1996-04-04 2001-01-30 Bristol-Myers Squibb Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics
EP0971910A1 (en) * 1997-04-02 2000-01-19 Merck Frosst Canada & Co. Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors
FR2775477B1 (en) * 1998-02-27 2000-05-19 Union Pharma Scient Appl NOVEL HETEROCYCLIC DIARYLMETHYLENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES
CN1106392C (en) * 2000-10-24 2003-04-23 中国科学院上海有机化学研究所 Butenolide containing no substituent at beta position and its synthesis process
WO2004041217A2 (en) * 2002-11-05 2004-05-21 Magnachem International Laboratories, Inc. Synthetic lactone formulations and method of use
EP1692101B1 (en) * 2003-03-31 2011-07-06 Council of Scientific and Industrial Research Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof
PL1745791T3 (en) 2003-05-07 2013-11-29 Osteologix As Treating cartilage/bone conditions with water-soluble strontium salts
US8779168B2 (en) * 2010-12-16 2014-07-15 Transitions Optical, Inc. Lactone compounds and materials made therefrom
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0679157T3 (en) * 1993-01-15 1998-07-27 Searle & Co Novel 3,4-diarylthiophenes and analogs thereof for use as anti-inflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge

Also Published As

Publication number Publication date
JP2000508638A (en) 2000-07-11
FR2747124B1 (en) 1998-06-26
NO984624D0 (en) 1998-10-02
CN1215396A (en) 1999-04-28
EE9800333A (en) 1999-04-15
IL126105A0 (en) 1999-05-09
KR20000005146A (en) 2000-01-25
AU2393397A (en) 1997-10-29
CA2248949A1 (en) 1997-10-16
SK283292B6 (en) 2003-05-02
GEP20032924B (en) 2003-03-25
BR9708510A (en) 1999-08-03
SI0891345T1 (en) 2002-02-28
ZA972894B (en) 1997-11-04
TW353660B (en) 1999-03-01
NO984624L (en) 1998-11-30
PT891345E (en) 2002-02-28
ATE204268T1 (en) 2001-09-15
BG62808B1 (en) 2000-08-31
EE03687B1 (en) 2002-04-15
NZ331672A (en) 2000-02-28
CZ318898A3 (en) 1999-01-13
AU717146B2 (en) 2000-03-16
FR2747124A1 (en) 1997-10-10
EP0891345B1 (en) 2001-08-16
EP0891345A1 (en) 1999-01-20
FR2747123B1 (en) 1998-06-26
BG102771A (en) 1999-06-30
WO1997037984A1 (en) 1997-10-16
DE69706157D1 (en) 2001-09-20
RU2189979C2 (en) 2002-09-27
IL126105A (en) 2001-08-26
DK0891345T3 (en) 2001-12-03
PL329213A1 (en) 1999-03-15
FR2747123A1 (en) 1997-10-10
SK137598A3 (en) 1999-02-11
DE69706157T2 (en) 2002-04-11
AR006539A1 (en) 1999-09-08

Similar Documents

Publication Publication Date Title
HN1999000124A (en) SUBSTITUTED PYRAZOLE DERIVATIVES.
DK0944643T3 (en) Oxyiminopregnancarbolactones.
ES2169147T3 (en) DERIVATIVES OF BETA-CARBOLINA AGONISTAS DE MELATONINA, ITS PREPARATION PROCEDURES AND ITS USE BY A MEDICINAL TITLE.
SV1997000009A (en) NEW SUBSTITUTED OXAZOLIDINONES REF. READ 31534-SV
UY26082A1 (en) DERIVATIVES OF 1,4-DIAZABICICLO [3.2.2] NONAN-4-CARBOXILATO AND -CARBOXAMIDAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
SV1997000003A (en) TIENIL- AND FURANIL-OXAZOLIDINONES PIRIDOCONDENSADAS REF. READ 31502-SV
HN2001000027A (en) PURINA DERIVATIVES
ES2159382T3 (en) STILBENIC COMPOUNDS WITH ADAMANTILO GROUP, COMPOSITIONS THAT CONTAIN THEM AND USES.
CY1112753T1 (en) HUMAN BODY CANCER TREATMENT BY USE TO743
ES2184131T3 (en) DERIVATIVES OF BENZAMIDINE AND ITS USE AS MEDICINES WITH ANTAGONIST EFFECT OF LTB4.
HN2002000300A (en) NEW DERIVATIVES OF PIPERAZINA
ES2183180T3 (en) NEW GUANIDINE DERIVATIVES, PROCEDURES FOR PREPARATION AND USE AS A MEDICINAL PRODUCT.
ES2172937T3 (en) 21-HYDROXI-6,19-OXIDOPROGESTERONE (21OH-6OP) AS A MEDICINAL PRODUCT TO TREAT THE EXCESS OF GLUCOCORTICOIDS.
SE9802206D0 (en) Novel compounds
ES2192680T3 (en) NEW DERIVATIVES OF VITAMIN D WITH CARBO- OR HETEROCICLIC SUBSTITUTES IN C-25, PROCEDURE FOR THE PREPARATION, INTERMEDIATE PRODUCTS AND THE USE FOR THE PREPARATION OF MEDICINES.
NO20013517D0 (en) Macrolides with anti-inflammatory activity
ES2162678T3 (en) NEW DIARILMETILIDENO FURANIC DERIVATIVES, THEIR PREPARATION PROCEDURES AND THEIR USES IN THERAPEUTICS.
MX9200396A (en) DERIVATIVES OF BENCILOXIFENILO, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
HN2001000235A (en) DERIVATIVES BRIDGES OF PIPERAZINA
ECSP034754A (en) DERIVATIVES OF BETA-CARBOLINA AND ITS PHARMACEUTICAL USE AGAINST DEPRESSION AND ANXIETY
ES2191449T3 (en) DERIVATIVES OF CICLOPENTABENZOFURANO AND ITS USE.
MX9204613A (en) ORGANIC NITRATES, PROCEDURES FOR ITS PREPARATION AND USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES
PA8509601A1 (en) "PIRAZOLO [4,3, e] NOVEDOUS REPLACED DIAZEPINS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, ITS USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM
ES2184424T3 (en) NEW HETEROETINYLENE COMPOUNDS AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM.
ES2062997T3 (en) SUBSTITUTED VINYLCEPHALOSPORINS, PROCEDURE FOR THEIR MANUFACTURE AND USE AS A MEDICINAL PRODUCT.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 891345

Country of ref document: ES